Menu

Fusion Pharmaceuticals Inc. FUSN

Full chart Compare
Set alert

Price alert · FUSN

All alert types
21.55 0.00 (+0.00%)

At closeJun 3, 2024, 4:00 PM EDT

21.48 Day range 21.58

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $5.12MExpenses → Selling, General & Admin: $31.20MExpenses → Research & Development: $68.76MExpenses → Income Tax: $787.00KGross Profit → Expenses: $723.00KRevenue → Gross Profit: $723.00KRevenue → Cost of Revenue: $1.34MNet Loss → Expenses: $94.90MOther Income$5.12MGross Profit$723.00KNet Loss$94.90MCost of Revenue$1.34MExpenses$100.74MSelling, General & Admin$31.20MResearch & Development$68.76MIncome Tax$787.00KRevenue$2.07M

Latest period ending Dec 31, 2023 · select a line to chart its full history

FUSN annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.07M1.46M1.44M00
2.07M1.46M1.44M00
-99.23M-88.03M-82.02M-37.94M-18.22M
-94.90M-87.61M-81.05M-78.33M-16.19M
-1.45-2.00-1.90-3.62-8.45
FUSN annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
62.77M45.33M54.79M92.41M67.12M
285.84M219.06M252.27M310.68M69.40M
63.36M56.84M20.82M16.16M10.34M
50.33M40.25M6.72M00
222.48M162.22M231.46M294.51M-33.49M
FUSN annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-81.80M-73.28M-75.74M-29.77M-13.69M
-42.76M23.09M37.77M-210.45M-456.00K
142.01M40.73M347.00K265.51M52.19M
-3.89M-2.14M-1.49M-1.12M-456.00K
17.44M-9.46M-37.62M25.29M38.04M